CRISPR THERAPEUTICS AG — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-345M
Free Cash Flow
$-346M
Investing Cash Flow
$-32M
Financing Cash Flow
$426M
Capex
$914K
Stock Buybacks
—
Stock-Based Comp
$72M
D&A
$19M
SBC Allocated Expense
$72M